metformin worwag
wörwag pharma gmbh & co. kg - metformino hidrochloridas - plėvele dengtos tabletės - 1000 mg - metformin
rennie
bayer, uab - kalcio karbonatas/magnio karbonatas - kramtomosios tabletės - 680 mg/80 mg - antacids, other combinations
vilspox
sandoz d.d. - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg; 50 mg/850 mg - metformin and vildagliptin
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antinavikiniai vaistai - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
vildagliptin/metformin teva
teva b.v. - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and vildagliptin
vildagliptin/metformin teva
teva b.v. - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and vildagliptin
tivulin
berlin-chemie ag - metformino hidrochloridas - pailginto atpalaidavimo tabletės - 500 mg - metformin
tivulin
berlin-chemie ag - metformino hidrochloridas - pailginto atpalaidavimo tabletės - 750 mg - metformin
tivulin
berlin-chemie ag - metformino hidrochloridas - pailginto atpalaidavimo tabletės - 1000 mg - metformin
eprocliv
sandoz d.d. - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - sitagliptin